Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity

doi:10.4239/wjd.v7.i20.572

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 20

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14856)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-17) series, Tables (1-2) series.

Item

Count

PDF

1012

WORD

328

HTML

9109

Figures (1-17)

539

Tables (1-2)

269

Sum=11257

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

659

Download

1016

Sum=1675

Publishing Process of This Article

Item

Count

Browse

797

Download

1127

Sum=1924

Dec 15, 2016 (publication date) through Jan 24, 2025

Times Cited of This Article

Times Cited (56)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Dec 15, 2016; 7(20): 572-598
Published online Dec 15, 2016. doi: 10.4239/wjd.v7.i20.572

Full Size Figure Download Figure

Figure 1 Global overweight and obesity trends and projections. If recent trends continue unabated, by 2030, 38% and 20% of the world’s adult population are projected to be overweight or obese respectively[8].

Citation: Anandhakrishnan A, Korbonits M. Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity. World J Diabetes 2016; 7(20): 572-598
URL: https://www.wjgnet.com/1948-9358/full/v7/i20/572.htm
DOI: https://dx.doi.org/10.4239/wjd.v7.i20.572